151 related articles for article (PubMed ID: 7518649)
1. Relationship of burst-forming-unit-erythroid progenitors and their DNA-synthesis stage to fetal hemoglobin levels in hydroxyurea-treated patients with sickle cell anemia.
Mankad VN; Baliga S; Phillips K; Shah AK; Yang YM
Am J Hematol; 1994 Aug; 46(4):259-63. PubMed ID: 7518649
[TBL] [Abstract][Full Text] [Related]
2. BFU-E colony growth in response to hydroxyurea: correlation between in vitro and in vivo fetal hemoglobin induction.
Yang YM; Pace B; Kitchens D; Ballas SK; Shah A; Baliga BS
Am J Hematol; 1997 Dec; 56(4):252-8. PubMed ID: 9395188
[TBL] [Abstract][Full Text] [Related]
3. Mechanism for fetal hemoglobin induction by hydroxyurea in sickle cell erythroid progenitors.
Baliga BS; Pace BS; Chen HH; Shah AK; Yang YM
Am J Hematol; 2000 Nov; 65(3):227-33. PubMed ID: 11074540
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneity in the properties of burst-forming units of erythroid lineage in sickle cell anemia: DNA synthesis and burst-promoting activity production is related to peripheral hemoglobin F levels.
Croizat H; Billett HH; Nagel RL
Blood; 1990 Feb; 75(4):1006-10. PubMed ID: 1689189
[TBL] [Abstract][Full Text] [Related]
5. Influence of hydroxyurea on fetal hemoglobin production in vitro.
Miller BA; Platt O; Hope S; Dover G; Nathan DG
Blood; 1987 Dec; 70(6):1824-9. PubMed ID: 2445401
[TBL] [Abstract][Full Text] [Related]
6. Hydroxyurea enhances fetal hemoglobin production in sickle cell anemia.
Platt OS; Orkin SH; Dover G; Beardsley GP; Miller B; Nathan DG
J Clin Invest; 1984 Aug; 74(2):652-6. PubMed ID: 6205021
[TBL] [Abstract][Full Text] [Related]
7. Erythroid progenitors in the peripheral blood of children with sickle cell disease.
West TB; Ohene-Frempong K; Stoeckert CJ; Surrey S
Am J Pediatr Hematol Oncol; 1994 May; 16(2):116-9. PubMed ID: 7513134
[TBL] [Abstract][Full Text] [Related]
8. Relationship between cell-cycle state of erythroid progenitors and fetal hemoglobin synthesis.
Isoyama K; Baliga S; Shah A; Mankad VN
Am J Hematol; 1992 Jan; 39(1):65-6. PubMed ID: 1371372
[TBL] [Abstract][Full Text] [Related]
9. Combined effects of arginine and hydroxyurea on BFU-E derived colony growth and HbF synthesis in erythroid progenitors isolated from sickle cell blood.
Baliga BS; Haynes J; Obiako B; Mishra N
Cell Mol Biol (Noisy-le-grand); 2010 Jun; 56 Suppl():OL1290-8. PubMed ID: 20937216
[TBL] [Abstract][Full Text] [Related]
10. Inhomogeneity of the circulating BFU-E regulation in sickle cell anaemia: accessory cells properties and BFU-E growth factor response pattern.
Croizat H; Nagel RL
Br J Haematol; 1993 Jul; 84(3):481-91. PubMed ID: 7692929
[TBL] [Abstract][Full Text] [Related]
11. Early circulating erythroid progenitors (BFU-E) in sickle cell anemia.
Croizat H
Experientia; 1993 Feb; 49(2):118-25. PubMed ID: 7680001
[TBL] [Abstract][Full Text] [Related]
12. In vitro induction of fetal hemoglobin in human erythroid progenitor cells.
Ho JA; Pickens CV; Gamcsik MP; Colvin OM; Ware RE
Exp Hematol; 2003 Jul; 31(7):586-91. PubMed ID: 12842703
[TBL] [Abstract][Full Text] [Related]
13. Hydroxyurea promotes the reduction of spontaneous BFU-e to normal levels in SS and S/beta thalassemic patients.
Bincoletto C; Perlingeiro RC; Saad ST; Costa FF; Queiroz ML
Hemoglobin; 2001 Feb; 25(1):1-7. PubMed ID: 11300342
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of F-cell production in patients with sickle-cell anemia treated with cytarabine or hydroxyurea.
Veith R; Galanello R; Papayannopoulou T; Stamatoyannopoulos G
N Engl J Med; 1985 Dec; 313(25):1571-5. PubMed ID: 2415821
[TBL] [Abstract][Full Text] [Related]
15. Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive "switching" agent. The Multicenter Study of Hydroxyurea in Sickle Cell Anemia.
Charache S; Barton FB; Moore RD; Terrin ML; Steinberg MH; Dover GJ; Ballas SK; McMahon RP; Castro O; Orringer EP
Medicine (Baltimore); 1996 Nov; 75(6):300-26. PubMed ID: 8982148
[TBL] [Abstract][Full Text] [Related]
16. Hydroxyurea induction of fetal hemoglobin synthesis in sickle-cell disease.
Dover GJ; Charache S
Semin Oncol; 1992 Jun; 19(3 Suppl 9):61-6. PubMed ID: 1379374
[TBL] [Abstract][Full Text] [Related]
17. Effects of dexamethasone on fetal hemoglobin synthesis in peripheral blood erythroid burst-forming units.
Steinberg MH; Coleman MB; Garver FA; Grenett HE; Pressley A; Adams JG
Am J Hematol; 1981; 10(1):37-45. PubMed ID: 6167163
[TBL] [Abstract][Full Text] [Related]
18. Circulating BFU-E in sickle cell anemia: relationship to percent fetal hemoglobin and BPA-like activity.
Croizat H; Nagel RL
Exp Hematol; 1988 Dec; 16(11):946-9. PubMed ID: 3181345
[TBL] [Abstract][Full Text] [Related]
19. Increased response of erythroid progenitors to interleukin-3 in sickle cell anemia: CFU-E-like behavior of circulating erythroid progenitors in liquid culture.
Isoyama K; Baliga S; Shah A; Mankad VN
Am J Hematol; 1991 Oct; 38(2):101-7. PubMed ID: 1951299
[TBL] [Abstract][Full Text] [Related]
20. Hematologic responses of patients with sickle cell disease to treatment with hydroxyurea.
Rodgers GP; Dover GJ; Noguchi CT; Schechter AN; Nienhuis AW
N Engl J Med; 1990 Apr; 322(15):1037-45. PubMed ID: 1690857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
